National Bank of Canada
WGS icon

National Bank of Canada’s GeneDx Holdings WGS Stock Holding History

National Bank of Canada’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15
Closed -$219K – 3041
2021
Q4 		$219K Buy
+15
New +$3.35K ﹤0.01% 1441

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

National Bank of Canada's WGS Position: Q1 2026 in Review

National Bank of Canada reduced its GeneDx Holdings (WGS) stake by 100% in Q1 2026, selling an estimated $2M and leaving 36 shares worth $2.31K. The position accounts for ﹤0.01% of the portfolio, ranked #2599.

National Bank of Canada first reported a position in WGS in Q4 2021 and has held it in 15 quarters since. The position peaked at $4.15M in Q2 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • National Bank of Canada held 36 shares of GeneDx Holdings worth $2.31K as of Q1 2026.
  • National Bank of Canada sold 21,964 GeneDx Holdings shares in Q1 2026, an estimated $2M.
  • GeneDx Holdings made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2599 holding.
  • National Bank of Canada first reported a position in GeneDx Holdings in Q4 2021 and has held it in 15 quarters since.
  • National Bank of Canada's GeneDx Holdings position peaked at $4.15M in Q2 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.